1. Home
  2. CDTX vs BJRI Comparison

CDTX vs BJRI Comparison

Compare CDTX & BJRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • BJRI
  • Stock Information
  • Founded
  • CDTX 2012
  • BJRI 1978
  • Country
  • CDTX United States
  • BJRI United States
  • Employees
  • CDTX N/A
  • BJRI N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • BJRI Restaurants
  • Sector
  • CDTX Health Care
  • BJRI Consumer Discretionary
  • Exchange
  • CDTX Nasdaq
  • BJRI Nasdaq
  • Market Cap
  • CDTX 980.1M
  • BJRI 983.0M
  • IPO Year
  • CDTX 2015
  • BJRI 1996
  • Fundamental
  • Price
  • CDTX $63.31
  • BJRI $35.43
  • Analyst Decision
  • CDTX Strong Buy
  • BJRI Hold
  • Analyst Count
  • CDTX 11
  • BJRI 5
  • Target Price
  • CDTX $52.11
  • BJRI $41.40
  • AVG Volume (30 Days)
  • CDTX 659.9K
  • BJRI 534.6K
  • Earning Date
  • CDTX 08-07-2025
  • BJRI 07-31-2025
  • Dividend Yield
  • CDTX N/A
  • BJRI N/A
  • EPS Growth
  • CDTX N/A
  • BJRI N/A
  • EPS
  • CDTX N/A
  • BJRI 0.95
  • Revenue
  • CDTX $302,000.00
  • BJRI $1,367,941,000.00
  • Revenue This Year
  • CDTX N/A
  • BJRI $5.58
  • Revenue Next Year
  • CDTX N/A
  • BJRI $2.93
  • P/E Ratio
  • CDTX N/A
  • BJRI $38.56
  • Revenue Growth
  • CDTX N/A
  • BJRI 2.91
  • 52 Week Low
  • CDTX $10.14
  • BJRI $27.61
  • 52 Week High
  • CDTX $66.95
  • BJRI $47.02
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 70.66
  • BJRI 25.95
  • Support Level
  • CDTX $60.71
  • BJRI $35.99
  • Resistance Level
  • CDTX $66.95
  • BJRI $39.24
  • Average True Range (ATR)
  • CDTX 4.25
  • BJRI 1.31
  • MACD
  • CDTX -0.39
  • BJRI -0.52
  • Stochastic Oscillator
  • CDTX 79.25
  • BJRI 6.24

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About BJRI BJ's Restaurants Inc.

BJ's Restaurants Inc is involved in the business of owning and operating restaurants. The company operates in a single operating segment that is full-service company-owned restaurants. It has geographic presence only in the United States of America.

Share on Social Networks: